Cargando…
Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth
Bone marrow (BM) mesenchymal stromal cells (MSCs) are abnormal in multiple myeloma (MM) and play a critical role by promoting growth, survival, and drug resistance of MM cells. We observed higher Toll-like receptor 4 (TLR4) gene expression in MM MSCs than in MSCs from healthy donors. At the clinical...
Autores principales: | Lemaitre, Léa, Hamaidia, Malik, Descamps, Jean-Gérard, Do Souto Ferreira, Laura, Joubert, Marie-Véronique, Gadelorge, Mélanie, Avet-Loiseau, Hervé, Justo, Arthur, Reina, Nicolas, Deschaseaux, Frederic, Martinet, Ludovic, Bourin, Philippe, Corre, Jill, Espagnolle, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791574/ https://www.ncbi.nlm.nih.gov/pubmed/34714910 http://dx.doi.org/10.1182/bloodadvances.2020003704 |
Ejemplares similares
-
Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells
por: Espagnolle, Nicolas, et al.
Publicado: (2020) -
Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma
por: Lemaitre, Léa, et al.
Publicado: (2020) -
CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment
por: Espagnolle, Nicolas, et al.
Publicado: (2014) -
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma
por: Puig, Noemí, et al.
Publicado: (2022) -
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
por: Stroh, Jacob, et al.
Publicado: (2022)